Haicheung Pharmaceutical shareholders after a number of small reduction, finally big shot to sell shares. Yesterday, the sea Xiang pharmaceutical industry said, the company's former largest shareholder Robonpeng "dozen 50 percent" will be held by the Sea Xiang Pharmaceutical 21.68% shares, 464 million yuan transfer to its son Rou, so that the chairman of the Sea Xiang pharmaceutical Rou 竑 holding 24.67% of the company into the largest shareholder. Last year, Robonpeng and his son-in-law Zhengzhiguo gradually reduce the sea Xiang pharmaceutical shares are now, each reduction ratio is under 2%, as of this large-scale reduction of shareholding tickets, has successfully set up now billion. Yesterday, Hai Xiang Pharmaceutical Industry Bulletin said that Robonpeng on September 17 with his son, Mr. Rou signed the "Equity transfer Agreement", the 34.8 million shares (21.68% of the total share capital) of the Sea Xiang Pharmaceutical shares to its son Rou, to the agreement to sign the closing price of the 50% as transfer prices, That is, the transfer price per share of RMB 13.325 yuan, the total price of the transfer is 463.71 million yuan. After the completion of this transaction, Hai Xiang Pharmaceutical industry's first major shareholder for the Rou, holding 24.67% of the sea Xiang pharmaceutical industry, and Robonpeng only hold the sea Xiang pharmaceutical industry 2.84% shares. Yesterday, Hai Xiang Pharmaceutical related people expressed their reluctance to express any opinions on the transfer of large shareholder shares, said Rou for the actual control of the sea Xiang Pharmaceutical, as the company's largest shareholder, can consolidate the stability of the company's equity structure, conducive to promoting the company's business and establish long-term strategic development planning. Yesterday, the pharmaceutical sector outstanding performance, more than 5% pharmaceutical stocks, Hai Xiang pharmaceutical industry closed 27.32 yuan, Rose 5.2%.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.